Regulation of Translesion DNA Synthesis: Posttranslational
Total Page:16
File Type:pdf, Size:1020Kb
DNA Repair 29 (2015) 166–179 Contents lists available at ScienceDirect DNA Repair j ournal homepage: www.elsevier.com/locate/dnarepair Regulation of translesion DNA synthesis: Posttranslational modification of lysine residues in key proteins a,∗ b Justyna McIntyre , Roger Woodgate a Institute of Biochemistry and Biophysics, Polish Academy of Sciences, ul. Pawinskiego 5a, 02-106 Warsaw, Poland b Laboratory of Genomic Integrity, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20892-3371, USA a r a t i b s c t l e i n f o r a c t Article history: Posttranslational modification of proteins often controls various aspects of their cellular function. Indeed, Received 27 October 2014 over the past decade or so, it has been discovered that posttranslational modification of lysine residues Received in revised form 9 February 2015 plays a major role in regulating translesion DNA synthesis (TLS) and perhaps the most appreciated lysine Accepted 10 February 2015 modification is that of ubiquitination. Much of the recent interest in ubiquitination stems from the fact Available online 18 February 2015 that proliferating cell nuclear antigen (PCNA) was previously shown to be specifically ubiquitinated at K164 and that such ubiquitination plays a key role in regulating TLS. In addition, TLS polymerases them- Keywords: selves are now known to be ubiquitinated. In the case of human polymerase , ubiquitination at four Translesion synthesis Ubiquitin lysine residues in its C-terminus appears to regulate its ability to interact with PCNA and modulate TLS. Within the past few years, advances in global proteomic research have revealed that many proteins Y-family polymerase PCNA involved in TLS are, in fact, subject to a previously underappreciated number of lysine modifications. In this review, we will summarize the known lysine modifications of several key proteins involved in TLS; PCNA and Y-family polymerases , , and Rev1 and we will discuss the potential regulatory effects of such modification in controlling TLS in vivo. © 2015 Published by Elsevier B.V. 1. Introduction e.g. SUMOylation, ISGylation, neddylation, FATylation and other lysine modifications such as acetylation, methylation, butyrylation, Posttranslational modifications (PTMs) of proteins by attach- crotonylation, glycation, malonylation, phosphoglycerylation, pro- ing different functional groups to amino acids widens the target pionylation, succinylation, myristoylation [1–4]. protein’s range of function and provides additional mechanisms Eukaryotic cells have evolved a plethora of mechanisms in order by which the modified protein can be regulated. For example, to protect genome stability by removing DNA lesions, or preventing PTMs can control a protein’s activity by influencing its ability to their conversion into permanent mutations [5]. Importantly, due interact with protein-partners, alter its enzymatic activity, sub- to partially overlapping functions of some of these pathways, or cellular localization, and change the stability of the protein. Of time and conditional cellular requirements, their actions need to all the experimentally identified PTMs in mammals, serine phos- be precisely controlled. Recent studies in the DNA repair field have phorylation is the most frequent modification followed by lysine, accumulated evidence of an ever expanding role of ubiquitination which represents over 15% of all experimentally identified amino in regulating diverse DNA repair mechanisms and pathways acid modifications (calculation based on data from [1]). Lysine involved in genomic stability maintenance (reviewed in [6]). can be modified in a variety of ways including, but not limited Ubiquitin- and ubiquitin-like-dependent signaling processes have to: ubiquitination, ubiquitin-like protein (UBL) modification an important function in controlling cellular responses to DNA damage by navigating through the range of DNA damage repair, or tolerance mechanisms (reviewed in [6–10]). The majority of DNA lesions are repaired by one of the specialized DNA repair pathways; Abbreviations: TLS, translesion synthesis; PCNA, proliferating cell nuclear anti- gen; pol, polymerase; PIP, PCNA-interacting peptide; RIR, Rev1-interacting region; however the repair processes can be slow and incomplete and as a UBM, ubiquitin binding motif; UBZ, ubiquitin binding zinc motif; pol, DNA poly- consequence a number of DNA lesions remain in the template DNA. merase iota; pol , DNA polymerase eta; pol, DNA polymerase kappa; UBL, This causes a severe problem, especially during the S-phase of the ubiquitin-like protein; PTM, posttranslational modification; PRR, post replication cell cycle, when DNA is replicated, because efficient and accurate DNA repair. ∗ classical DNA polymerases are blocked at DNA lesions. At this Corresponding author. Tel.: +48 22 5921115. E-mail address: [email protected] (J. McIntyre). critical juncture, distinct mechanisms are required to temporarily http://dx.doi.org/10.1016/j.dnarep.2015.02.011 1568-7864/© 2015 Published by Elsevier B.V. J. McIntyre, R. Woodgate / DNA Repair 29 (2015) 166–179 167 tolerate cellular DNA damage, thereby avoiding the permanent E4s [34,35]. Ubiquitination can be reversed through the activity block to the replication fork and the threat of cell cycle arrest. Lesion of de-ubiquitinating enzymes (DUBs), which primarily disassem- tolerance can be achieved in two different ways; one via a damage ble polyubiquitin chains before protein degradation, but will also avoidance pathway using the information from the undamaged cleave off a single ubiquitin moiety, or a polyubiquitin chain to sister chromatid as a template for replication of the damaged regulate protein functionality [36]. DNA region, or via translesion synthesis (TLS), which employs specialized DNA polymerases to synthesize past the lesion. 2.2. Ubiquitin-like posttranslational modification Over the past dozen years, it has become evident that modifica- tion of lysine residues through the covalent linkage of ubiquitin, or Besides ubiquitin, at least 10 different ubiquitin-like proteins ubiquitin-like proteins, plays a central role in controlling both DNA (UBLs) exist in mammals (reviewed in [37,38]) with SUMO, NEDD8 damage avoidance mechanisms and TLS. This review will attempt and ISG15 being the best known. UBL modifiers, similar to ubiqui- to summarize the known sites and cellular effects of ubiquitin- tin, form an isopeptide bond between their C-terminal glycine and ation of several key proteins involved in TLS. We will recap the lysine residues of the substrate [38]. UBLs often have low sequence individually discovered and experimentally confirmed sites of ubi- homology, but share a similar three-dimensional structure [38]. quitination and ubiquitin-like modifications of TLS proteins and Posttranslational modification with UBL proteins can alter cellular combine them with recent data derived from multiple proteome- function, stability, interactions with protein partners, or subcellu- wide approaches that reveal a hitherto underappreciated extent of lar localization of the target protein [37,39]. Protein modification lysine ubiquitination of many of the TLS proteins. by UBLs follows the same three-step cascade similar to ubiquit- ination in that it is catalyzed by sets of analogous activation (E1), conjugation (E2s) and ligation (E3s) enzymes and can be reversed 2. Types of lysine modifications by deconjugating enzymes [40]. SUMO (Small Ubiquitin-like MOdifier) is the most studied UBL 2.1. Ubiquitination modifier and is expressed in all eukaryotes, mainly as a sin- gle variant. However in human cells there are four different In eukaryotic cells, ubiquitination is involved in the regulation paralogs (SUMO1–4), representing various homology, expression of almost all cellular processes, including cell division, membrane levels and substrate preferences. Many proteins interacting with a transport, signal transduction, DNA repair, endocytosis, inflamma- SUMOlyated substrate possess specific SIM domains (from SUMO- tory signaling, apoptosis, etc. [11–14]. It has been estimated that interaction motif) [41]. SUMOylation of a target protein can roughly 10% of human genes encode for proteins involved in ubiqui- influence the protein degradation, signal transduction, localiza- tin metabolism [15]. The malfunction of ubiquitination processes tion, transcription activation, cell cycle, chromatin organization, and ubiquitin-mediated proteolysis has been implicated in various DNA repair and other functions (reviewed in [42]). Dysfunction of pathologies, including neurodegenerative disorders, inflammatory SUMOylation can lead to neurodegenerative diseases, heart defects, diseases and cancers [16–19]. Due to their important cellular diabetes or cancer [42–45]. functions, ubiquitination pathways are significant targets for ther- One ubiquitin-like molecule, ISG15 (the interferon-stimulated apeutics [20,21]. gene 15), has a primary sequence that consists of two domains Protein ubiquitination is a dynamic and reversible process with significant similarity to ubiquitin [46]. Interestingly, ISGyla- where a three-step enzymatic cascade conjugates a small, regu- tion shares some of the E2 and E3 enzymes used in ubiquitination latory protein, ubiquitin, to a specific lysine residue in a target and ISGylated proteins can also be targeted for degradation by the protein [22]. Initially, one of the ubiquitin-activating enzymes (E1s) 20S proteasome [47,48]. ISG15 is only found in vertebrates. Type forms